You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 6,444,652


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,444,652
Title: .beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B
Abstract:This invention is directed to a method for treating a host infected with hepatitis B comprising administering an effective amount of an anti-HBV biologically active 2'-deoxy-.beta.-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof, wherein the 2'-deoxy-.beta.-L-erythro-pentofuranonucleoside has the formula: ##STR1## wherein R is selected from the group consisting of H, straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-alkoxyalkyl, CO-aryloxyalkyl, CO-substituted aryl, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl, amino acid residue, mono, di, or triphosphate, or a phosphate derivative; and BASE is a purine or pyrimidine base which may be optionally substituted. The 2'-deoxy-.beta.-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof may be administered either alone or in combination with another 2'-deoxy-.beta.-L-erythro-pentofuranonucleoside or in combination with another anti-hepatitis B agent.
Inventor(s): Gosselin; Gilles (Montpellier, FR), Imbach; Jean-Louis (Montpellier, FR), Bryant; Martin L. (Carlisle, MA)
Assignee: Novirio Pharmaceuticals Limited (Grand Cayman, CY) Centre National da la Recherche Scientifique (Paris, FR)
Application Number:09/459,150
Patent Claim Types:
see list of patent claims
Use; Compound; Composition;
Patent landscape, scope, and claims:

United States Patent 6,444,652: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,444,652 is a significant patent that has been involved in various legal and regulatory proceedings. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The patent in question, U.S. Patent No. 6,444,652, was issued to protect specific inventions related to pharmaceuticals. Here is a brief overview:

  • Patent Number: 6,444,652
  • Issue Date: This information is not provided in the sources, but it is referenced in the context of other patents and regulatory filings.
  • Inventors and Assignees: The specific inventors and assignees are not detailed in the provided sources, but such information can typically be found in the patent document itself or through patent databases[4].

Scope and Claims

The scope and claims of a patent are crucial in understanding what is protected and how it applies to products or methods.

Claims

The claims of U.S. Patent No. 6,444,652 are not explicitly detailed in the provided sources. However, claims typically include descriptions of the invention, its components, and how it operates. For pharmaceutical patents, claims often cover the drug substance, its polymorphs, methods of use, and methods of manufacture[1].

Scope

The scope of the patent is defined by its claims and the descriptions provided in the patent specification. For example, if the patent claims a method of using an active ingredient, it would specify how that ingredient is used, potentially including dosage, administration routes, and therapeutic indications[1].

Regulatory Extensions and Filings

The patent has been involved in regulatory extensions, particularly in the context of pharmaceutical approvals.

Patent Term Extension

The patent was subject to a term extension under 35 U.S.C. ยง 156, which allows for the extension of a patent term due to regulatory delays. The extension was calculated based on the time spent in the testing and approval phases of the drug. For instance, the period from the IND application to the NDA submission and the subsequent approval phase were considered in determining the extension period[1].

Terminal Disclaimer

A terminal disclaimer was filed to disclaim the terminal part of the patent extending beyond the expiration of other related patents. This ensures that the patent does not extend beyond the expiration dates of other relevant patents[1].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the broader context of related patents and how they interact.

Related Patents

The patent is linked to other patents, such as U.S. Patent No. 6,569,837, which also underwent a term extension. These patents collectively protect a range of inventions related to the same or similar products or methods[1].

Claim Coverage Matrix

A Claim Coverage Matrix can be used to analyze which patents and claims are actively protecting the intellectual property. This tool helps in identifying gaps or opportunities in the patent coverage and can be particularly useful in managing a large portfolio of patents[3].

Global Patent System

The patent is part of a global patent system, where similar patents may have been filed in other jurisdictions. Tools like the Global Dossier and Common Citation Document (CCD) can help in tracking related applications and citations across different intellectual property offices[4].

Maintenance and Fees

Patent maintenance involves regular fee payments to keep the patent in force.

Maintenance Fees

The patent requires periodic maintenance fees to remain active. For example, the 8th year maintenance fee for U.S. Patent No. 6,444,652 would be due several years after the patent's issuance, ensuring the patent remains in force until its expiration date[1].

Abandonment and Reinstatement

While not directly applicable to U.S. Patent No. 6,444,652, understanding the process of abandonment and reinstatement is crucial. Patents can be deemed abandoned if maintenance fees are not paid or if there is a failure to respond to notices. Reinstatement is possible under certain conditions, but it must be done within specified timeframes[2].

Search and Analysis Tools

Several tools are available for searching and analyzing patents.

Patent Public Search

The USPTO's Patent Public Search tool allows for comprehensive searches of patent databases, including prior art and related applications[4].

Global Dossier and CCD

These tools provide access to file histories and citation data from participating IP offices, facilitating a more integrated global patent search[4].

Conclusion

U.S. Patent No. 6,444,652 is a significant patent within the pharmaceutical sector, protected by a detailed set of claims and subject to regulatory extensions. Understanding its scope, claims, and the broader patent landscape is essential for managing intellectual property effectively.

Key Takeaways

  • Patent Scope and Claims: Define what is protected, including drug substances, methods of use, and methods of manufacture.
  • Regulatory Extensions: Allow for the extension of patent terms due to regulatory delays.
  • Patent Landscape: Involves analyzing related patents and using tools like Claim Coverage Matrices and Global Dossier.
  • Maintenance Fees: Regular payments are necessary to keep the patent in force.
  • Search and Analysis Tools: Utilize tools like Patent Public Search, Global Dossier, and CCD for comprehensive patent analysis.

Frequently Asked Questions (FAQs)

What is the purpose of a patent term extension?

A patent term extension is granted to compensate for the time spent in regulatory review, ensuring the patent holder has a reasonable period to exploit the invention after regulatory approval.

How are patent claims analyzed in a Claim Coverage Matrix?

A Claim Coverage Matrix categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.

What happens if a patent maintenance fee is not paid?

If a patent maintenance fee is not paid, the patent can be deemed abandoned. However, it may be possible to reinstate the patent by paying the required fees and any additional penalties within a specified timeframe.

How can the Global Dossier tool be used in patent analysis?

The Global Dossier tool provides access to the file histories of related applications from participating IP offices, allowing users to see the patent family, classification, and citation data for these applications.

What is the Common Citation Document (CCD) and its purpose?

The Common Citation Document (CCD) consolidates prior art cited by participating IP offices for the family members of a patent application, enabling users to visualize search results on a single page and facilitating greater integration of the global patent system.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,444,652

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,444,652

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1104436 ⤷  Subscribe CA 2007 00038 Denmark ⤷  Subscribe
European Patent Office 1104436 ⤷  Subscribe 91348 Luxembourg ⤷  Subscribe
European Patent Office 1104436 ⤷  Subscribe 300286 Netherlands ⤷  Subscribe
European Patent Office 1104436 ⤷  Subscribe 07C0046 France ⤷  Subscribe
European Patent Office 1104436 ⤷  Subscribe C01104436/01 Switzerland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.